Adagio Medical Holdings Inc ADGM

$1.75 +0.09 (5.42%)

Valuation

Market cap
1,721,000
Revenue TTM
$0
Net income TTM
$-25,080,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
-59.14

Trading

Volume
27,700
Avg volume
116,292
Day's range
$1.60 – $1.87
Shares out
983,000
Stochastic %K
38%
Beta
0.07
Analysts
Moderate Buy
Price target
$120.12

Price

Company profile

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC ca...

Show more

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Industry
Medical Devices
Sector
Healthcare
Phone
949 348 1188
Website
https://adagiomedical.com
Address
26051 Merit Circle, Suite 102, Laguna Hills, United States

Latest news

Stocktwits

87trades Nov 22, 12:51 AM
$ADGM This is a key factor for anticipating a PMA decision before year end. They worked with FDA on a modular approach, with clinical data being the final part submitted. FDA is aiming for 90% of PMA approval to be done in 180 days. We are right in the window for news.
0 replies
87trades Nov 20, 9:51 PM
$ADGM will the stock price be over or under $1 on Dec 4th? Another reverse split vote is now set. Next filing will be re-opening note conversion at alternate price. But hey at least we regained compliance today!!
0 replies
87trades Nov 20, 9:08 PM
$ADGM 🤝 $ATRC Atricure is the ideal company to buy Adagio in an all stock deal. They have footprint in AF market, they have exposure to cryo through pain management position, and they could help navigate next gen trial to completion.
0 replies
Doxtator Nov 20, 7:48 PM
$ADGM I'd make a liquidation bid. Anyone want to run a MedTech?
3 replies
87trades Nov 20, 1:56 PM
$ADGM the most obvious short to the algo. They are dropped a 1/1000 reverse split proxy on the 11/10, shareholders at end of day on 11/16 will be able to vote. Official proxy vote info likely hits after close today or on Monday. If they announce they are opening lower conversion price window again, that is all she wrote for Adagio. Holding on to my shares with a firm stop loss. So unfortunate.
1 replies
GridironGainz Nov 19, 10:14 PM 0 replies
GridironGainz Nov 19, 9:23 PM 0 replies
87trades Nov 19, 9:14 PM
$ADGM this Adagio’s challenge in VT space with PFA proliferation. @AdagioMedical
0 replies